Tetralogic Pharmaceuticals
www.tetralogicpharma.comTetraLogic Pharmaceuticals (Nasdaq: TLOG) is a clinical-stage biopharmaceutical company focused on discovering, acquiring and developing novel product candidates to treat cancer and infectious diseases. We currently have two clinical-stage product candidates in development: birinapant and suberohydroxamic acid (4-methoxycarbonyl) phenyl ester (SHAPE).
Read more
TetraLogic Pharmaceuticals (Nasdaq: TLOG) is a clinical-stage biopharmaceutical company focused on discovering, acquiring and developing novel product candidates to treat cancer and infectious diseases. We currently have two clinical-stage product candidates in development: birinapant and suberohydroxamic acid (4-methoxycarbonyl) phenyl ester (SHAPE).
Read more
Employees statistics
View all employeesPotential Decision Makers
Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Accounting Manager
Email ****** @****.comPhone (***) ****-****Regulatory Affairs and Quality Control Manager
Email ****** @****.comPhone (***) ****-****Senior Scientist
Email ****** @****.comPhone (***) ****-****
Technologies
(7)
Reach decision makers at Tetralogic Pharmaceuticals
Free credits every month!
Tetralogic Pharmaceuticals FAQ
Biotechnology Research
